Consun Pharma Maintains 841.55 Million Issued Shares in April; Public Float Remains Compliant

Bulletin Express

May 04

Consun Pharmaceutical Group Limited reported no changes in its share structure for the month ended 30 April 2026, according to the company’s latest monthly return filed with the Hong Kong Stock Exchange on 4 May 2026.

• Authorised share capital remained at 5.00 billion ordinary shares with a par value of HKD 0.10, equivalent to HKD 500.00 million.

• Issued share capital was unchanged at 841.55 million shares, with no treasury shares outstanding or cancelled during the period.

• The company confirmed compliance with the Main Board’s 25% minimum public-float requirement as at month-end.

Share-based Incentives

• 2013 Share Option Scheme: 7.07 million options were outstanding, with no exercises, cancellations, or new grants in April.

• 2024 Share Option Scheme: no options were outstanding, while the scheme’s unutilised limit allows issuance of up to 84.28 million shares.

No warrants, convertible securities, or other equity arrangements were reported for the month. The filing was signed by Company Secretary Gao Haien, confirming all regulatory requirements were met.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1182868940"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1182868940\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1182868940?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-04 17:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182868940","market":"hk","top_or_hot":-1,"title":"Consun Pharma Maintains 841.55 Million Issued Shares in April; Public Float Remains Compliant","media":"Bulletin Express","content":"<p>Consun Pharmaceutical Group Limited reported no changes in its share structure for the month ended 30 April 2026, according to the company’s latest monthly return filed with the Hong Kong Stock Exchange on 4 May 2026.</p>\n<p>• Authorised share capital remained at 5.00 billion ordinary shares with a par value of HKD 0.10, equivalent to HKD 500.00 million.</p>\n<p>• Issued share capital was unchanged at 841.55 million shares, with no treasury shares outstanding or cancelled during the period.</p>\n<p>• The company confirmed compliance with the Main Board’s 25% minimum public-float requirement as at month-end.</p>\n<p>Share-based Incentives</p>\n<p>• 2013 Share Option Scheme: 7.07 million options were outstanding, with no exercises, cancellations, or new grants in April.</p>\n<p>• 2024 Share Option Scheme: no options were outstanding, while the scheme’s unutilised limit allows issuance of up to 84.28 million shares.</p>\n<p>No warrants, convertible securities, or other equity arrangements were reported for the month. The filing was signed by Company Secretary Gao Haien, confirming all regulatory requirements were met.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consun Pharma Maintains 841.55 Million Issued Shares in April; Public Float Remains Compliant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsun Pharma Maintains 841.55 Million Issued Shares in April; Public Float Remains Compliant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-04 17:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Consun Pharmaceutical Group Limited reported no changes in its share structure for the month ended 30 April 2026, according to the company’s latest monthly return filed with the Hong Kong Stock Exchange on 4 May 2026.</p>\n<p>• Authorised share capital remained at 5.00 billion ordinary shares with a par value of HKD 0.10, equivalent to HKD 500.00 million.</p>\n<p>• Issued share capital was unchanged at 841.55 million shares, with no treasury shares outstanding or cancelled during the period.</p>\n<p>• The company confirmed compliance with the Main Board’s 25% minimum public-float requirement as at month-end.</p>\n<p>Share-based Incentives</p>\n<p>• 2013 Share Option Scheme: 7.07 million options were outstanding, with no exercises, cancellations, or new grants in April.</p>\n<p>• 2024 Share Option Scheme: no options were outstanding, while the scheme’s unutilised limit allows issuance of up to 84.28 million shares.</p>\n<p>No warrants, convertible securities, or other equity arrangements were reported for the month. The filing was signed by Company Secretary Gao Haien, confirming all regulatory requirements were met.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01681","symbol_name":"康臣药业","start_time":0,"source_url":"","article_id":"1182868940","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182868940","pubTimestamp":1777885615,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Consun Pharmaceutical Group Limited reported no changes in its share structure for the month ended 30 April 2026, according to the company’s latest monthly return filed with the Hong Kong Stock...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01681":"康臣药业"},"translate_title":"康臣药业4月维持8.4155亿股已发行股份；公众持股量保持合规","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"Consun Pharmaceutical Group Limited reported no changes in its share structure for the month ended 30 April 2026, according to the company’s latest monthly return filed with the Hong Kong Stock Exchange on 4 May 2026.\n• Authorised share capital remained at 5.00 billion ordinary shares with a par value of HKD 0.10, equivalent to HKD 500.00 million.\n• Issued share capital was unchanged at 841.55 million shares, with no treasury shares outstanding or cancelled during the period.\n• The company confirmed compliance with the Main Board’s 25% minimum public-float requirement as at month-end.\nShare-based Incentives\n• 2013 Share Option Scheme: 7.07 million options were outstanding, with no exercises, cancellations, or new grants in April.\n• 2024 Share Option Scheme: no options were outstanding, while the scheme’s unutilised limit allows issuance of up to 84.28 million shares.\nNo warrants, convertible securities, or other equity arrangements were reported for the month. The filing was signed by Company Secretary Gao Haien, confirming all regulatory requirements were met.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}